Pharmaceutical tetrahydroisoquinolines
US5118690A · kind A · utility
6Cited by
2References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 1991 |
| Grant date | Jun 2, 1992 |
| Priority date | — |
| Expiry date | Oct 21, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention concerns a method for treating pain and/or CNS disorders characterized in that the method uses a compound which acts selectively as an antagonist of gamma aminobutyric acid (GABA) at GABA autoreceptors relative to GABA.sub.A receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.